RecallWatchUSA

Home / Brands / Lowlite Investments, Inc.

Lowlite Investments, Inc. Recalls

105 recalls on record · July 17, 2013 to July 17, 2013 · Drugs

July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Yohimbine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Xylazine 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Vitamin B-Buildup Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Vitamin B12 Cyanocobalamin 5000 mcg Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Vitamin B12 (3000 mcg/ml & 5000 mcg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Vitamin A/D3/E Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Tripelennamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Trimix, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Testosterone Cypionate (100 mg/ml & 200 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Taurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Sodium Salicylate 40% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Sodium Iodide 20% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Sermorelin/GHRP 3 mg/3 mg vial, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Quadmix, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Progesterone EO 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Progesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Praziquantel 56.8mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Potassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Phenylbutazone 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Phentolamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Phenobarbital 62. 5mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Pentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Lowlite Investments, Inc. Recalls | RecallWatchUSA